openPR Logo
Press release

The global market for stem cell therapy is estimated at US$ 9.5 billion in 2022 and is expected to grow significantly during the forecast period. The constant development in stem cell therapies is expected to drive market growth in the upcoming years. Rat

12-07-2022 09:26 AM CET | Health & Medicine

Press release from: RationalStat LLC

Global market for stem cell therapy

Global market for stem cell therapy

The report titled "Global Stem Cell Therapy Market" assesses the stem cell therapy market globally based on product, therapy type, technology, therapeutic application, end-use, and region. A comprehensive report provides a detailed historical and future market size with a trend analysis.
RationalStat provides market share analysis, production capabilities of the top companies, Covid-19 impact analysis, competition overview across the target markets, market strategies, and potential growth areas for the target players studied in the global stem cell therapy market.

Market Overview and Dynamics: Growth of Stem Cell Therapies in the Global market to be backed by government support

The global stem cell therapy market is expected to grow at a CAGR of around 9% during the forecast period of 2022-2028. The constantly increasing research and development activities in stem cell therapies by major players in the market are anticipated to play a key role in the growth of the global stem cell therapy market. R&D activities will result in the creation of new and advanced products offering enhanced protection. This is expected to attract the majority of the population as new products are comparatively reliable and safe to use. For instance,
• In December 2019, Mayo Clinic commenced a phase I clinical trial to assess the safety and feasibility of mesenchymal stem cell treatment in patients with intracerebral hemorrhage. This treatment is used to treat acute spontaneous hemorrhagic stroke.
• In July 2018, the Emory Orthopedics & Spine Center, in collaboration with Sanford Health, Duke University, Andrews Institute, and Georgia Institute of Technology, received a US$ 13 million grant from the Marcus Foundation for a multicenter clinical trial studying stem cell options for treating osteoarthritis.
Besides, the emergence of chronic diseases and the rise in GMP certification approvals for cell therapy production are some of the major drivers responsible for the growth of the global stem cell therapy market. Furthermore, the growth of the biotechnology sector is expected to influence the growth of the global stem cell therapy market as it helps in developing tools and therapeutics through the modification and engineering of stem cells.
In addition, significant government funding and initiatives for regenerative medicine research and development activities in the developed region will further stimulate market growth.
• For instance, the Medical Research Future Fund (MRFF) announced the Stem Cell Therapies Mission as part of the 2019-20 budget. Nearly US$ 150 million was allocated by the Australian government to research and development of safe and effective medicines for all afflicted people.

Segmental Analysis

• Based on therapy type, allogeneic stem cell therapy holds a dominant share in the global stem cell therapy market and is expected to maintain its position in the upcoming years. This is majorly due to the use of allogeneic stem cells in the treatment of various cancer types including lymphomas, leukemia, and myelomas due to its graft-vs.-cancer effect.
• Based on the Therapeutic application, oncology holds a prominent share in the global stem cell therapy market as stem cell therapy finds application in the treatment of a variety of cancers. Other departments like Orthopedic, Neurology, Cardiovascular & Myocardial Infraction, and Hematology hold a significant share of the global stem cell therapy market.
• Based on region, North America dominates the global stem cell therapy market owing to the increasing research and development activities coupled with constant government support. Other regions like Europe and the Asia Pacific are expected to grow significantly in the forecast period.

Competition Analysis: Increasing number of clinical trials and R&D activities to lead the growth of the global stem cell therapy market in the upcoming years

Due to the presence of many well-established companies in the global stem cell therapy market, there is intense competition in the global stem cell therapy market. The global stem cell therapy market is expected to witness a pool of export opportunities due to the increasing prevalence of chronic diseases and increasing cases of cancer, growing awareness of the global population about preventive healthcare, and gradually improving healthcare infrastructure.
Regulatory approvals, manufacturing expansion, and innovation in therapies are the key industrial activities observed in the global stem cell therapy market. Significant consolidation is expected in the global stem cell therapy market during the forecasting period 2022-2028.
• In March 2021, NOVADIP Biosciences S.A. gained FDA approval for its Investigational New Drug (IND) application for its autologous cell treatment product NVD-003. This strategy is expected to boost their market position by improving their product offerings and expanding their consumer base.
• In April 2020, Seneca Biopharma Inc. announced the completion of its new cell manufacturing facility in Suzhou, China. The company will manufacture NSI-566 in this new facility, which is the company's leading stem cell therapy.

Some of the prominent players operating in the market include Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, BioTime Inc., Mesoblast Ltd., Seneca Biopharma Inc., Opexa Therapeutics Inc., Pluristem Therapeutics Inc., STEMCELL Technologies Inc., ThermoGenesis Holdings Inc., Astellas Pharma Inc., and Caladrius Biosciences Inc. among others.

RationalStat has segmented the global stem cell therapy market on the basis of product, therapy type, technology, therapeutic application, end-use, and region.
• By Product
o Adult Stem Cells (ASCs)
 Hematopoietic
 Mesenchymal
 Neural
 Others (Epithelial/Skin)
o Human Embryonic Stem Cells (HESCs)
o Induced Pluripotent Stem Cells (iPSCs)
o Very Small Embryonic-Like Stem Cells
• By Therapy Type
o Allogeneic Stem Cell Therapy
o Autologous Stem Cell Therapy
• By Technology
o Cell Acquisition
 Bone Marrow Harvest
 Umbilical Blood Cord
 Apheresis
o Cell Production
 Therapeutic Cloning
 In-vitro Fertilization
 Cell Culture
 Isolation
o Cryopreservation
o Expansion and Sub-culture
• By Therapeutic Application
o Oncology
o Orthopedic
o Neurology
o Cardiovascular & Myocardial Infraction
o Hematology
o Others (Wounds & Injuries, Liver Disorders, Diabetes, etc.)
• By End Use
o Hospitals
o Research Organizations
• By Region
o North America
 US
 Canada
o Latin America
 Brazil
 Mexico
 Rest of Latin America
o Western Europe
 Germany
 UK
 France
 Spain
 Italy
 Rest of Western Europe
o Eastern Europe
 Russia
 Poland
 Rest of Eastern Europe
o Asia Pacific
 China
 Japan
 India
 South Korea
 Australia
 ASEAN (Indonesia, Vietnam, Malaysia, etc.)
 Rest of Asia Pacific
o Middle East & Africa
 GCC
 South Africa
 Turkey
 Rest of the Middle East & Africa

For more information about this report https://store.rationalstat.com/store/global-stem-cell-therapy-market-investment-growth-opportunity-analysis/

RationalStat LLC
Kimberly Shaw, Content and Press Manager
sales@rationalstat.com
Phone: +1 302 803 5429

RationalStat is an end-to-end US-based market intelligence and consulting company that provides comprehensive market research reports along with customized strategy and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The global market for stem cell therapy is estimated at US$ 9.5 billion in 2022 and is expected to grow significantly during the forecast period. The constant development in stem cell therapies is expected to drive market growth in the upcoming years. Rat here

News-ID: 2837249 • Views:

More Releases from RationalStat LLC

Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Forecast 2023-2030
Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Fore …
The global lipstick filling machine market is expected to reach US$ 88.2 million by 2030, with an annual growth rate of more than 4.5%. According to RationalStat's recent industry analysis, the Global Lipstick Filling Machine Market value is estimated at US$ 64.8 million in 2023 and is expected to rise at a strong CAGR of over 4.5% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview A lipstick
Published Market Report | Global Railway Systems Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Railway Systems Market Size, Share, & Forecast …
The global railway systems market is expected to reach US$ 29.2 billion by 2030, with an annual growth rate of more than 3.6%. According to RationalStat's recent industry analysis, the Global Railway Systems Market value is estimated at US$ 22.8 billion in 2023 and is expected to rise at a strong CAGR of over 3.6% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Railway systems, also known
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 20 …
The global window blinds market is expected to reach US$ 3.7 billion by 2030, with an annual growth rate of more than 3.8%. According to RationalStat's most recent industry analysis, the Global Window Blinds Market value is estimated at US$ 2.9 billion in 2023 and is expected to rise at a strong CAGR of over 3.8% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Window blinds are
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream Manufacturing Plant Market Analysis, Trends, Growth Opportunities, and Forecast, 2023-2030
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream M …
The global ointment and cream manufacturing plant market is expected to approach US$ 388.7 million by 2030, with an annual growth rate of more than 5.9% Global Ointment and Cream Manufacturing Plant Market is valued at US$ 260.9 million in 2023 and is expected to grow at a significant CAGR of over 5.9% over the forecast period of 2023-2030, according to the published market report by RationalStat Market Definition, Market

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY